Medicare Enrolled

Dr. David Reed, M.D.

Ophthalmology · Plymouth, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
146 INDUSTRIAL PARK RD, Plymouth, MA 02360
5088336000
In practice since 2009 (16 years)
NPI: 1932330990 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reed? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reed

Dr. David Reed is an ophthalmology specialist in Plymouth, MA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Reed performed 62,829 Medicare services across 8,646 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reed received a total of $1,906 from 9 pharmaceutical and/or device companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 0% volume in MA $1,906 industry payments

Medicare Practice Summary

Medicare Utilization ↗
62,829
Medicare services
Top 0% in MA for ophthalmology
8,646
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,927 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
34,329 $29 $100
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
7,796 $31 $161
Aflibercept eye injection (Eylea) 7,406 $692 $2,500
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
4,974 $98 $932
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
3,368 $91 $400
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
1,550 $55 $103
Ranibizumab-nuna biosimilar injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-nuna (Byooviz) at a dose of 0.1 mg.
1,105 $156 $800
Injection, ranibizumab, 0.1 mg 546 $183 $840
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
424 $65 $250
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
308 $158 $390
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
306 $70 $275
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
245 $19 $95
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
197 $105 $450
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
78 $26 $215
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
75 $49 $290
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
40 $40 $350
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
33 $915 $4,235
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
21 $1,746 $5,629
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
15 $186 $1,633
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
13 $506 $4,125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$1,906
Total received (2018-2023)
Avg $381/year across 5 years
Top 32% in MA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
9
Companies
23
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,222 (64.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$684 (35.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$1,222
2022
$156
2020
$16
2019
$171
2018
$341

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Regeneron Pharmaceuticals, Inc.
$1,222
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Regeneron Pharmaceuticals, Inc.
$1,222
Regeneron Healthcare Solutions, Inc.
$331
Allergan Inc.
$237
Sight Sciences, Inc.
$28
Alimera Sciences, Inc.
$20
Genentech USA, Inc.
$19
Novartis Pharmaceuticals Corporation
$17
Shire North American Group Inc
$16
Allergan, Inc.
$16
Top 3 companies account for 93.9% of all-time payments
Associated products mentioned in payments ›
BEOVU · COMBIGAN · EYLEA · EYLEA AFLIBERCEPT INJECTION · OMNI · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · VABYSMO · XIIDRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for an ophthalmology specialist in Plymouth?
Compare ophthalmologists in the Plymouth area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
15
Per 100K population
2.8
County median income
$109,698
Nearest hospital
BETH ISRAEL DEACONESS HOSPITAL PLYMOUTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reed is a mixed practice specialist, with above-average Medicare volume (top 0% in MA), with consulting-driven industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Reed experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Reed performed 34,329 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reed receive payments from pharmaceutical companies?
Yes. Dr. Reed received a total of $1,906 from 9 companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reed's costs compare to other ophthalmologists in Plymouth?
Dr. Reed's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →